CIP
AVNS

Chartwell Investment Partners’s Avanos Medical AVNS Stock Holding History

Chartwell Investment Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-57,519
Closed -$2.58M – 436
2018
Q4 		$2.58M Sell
57,519
-34,819
-38% -$1.82M 0.09% 298
2018
Q3 		$6.33M Buy
92,338
+129
+0.1% +$8.3K 0.19% 178
2018
Q2 		$5.28M Buy
92,209
+43,719
+90% +$2.31M 0.16% 196
2018
Q1 		$2.23M Sell
48,490
-1,005
-2% -$47.7K 0.08% 279
2017
Q4 		$2.29M Sell
49,495
-3,043
-6% -$140K 0.08% 314
2017
Q3 		$2.37M Buy
+52,538
New +$2.24M 0.08% 302

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Chartwell Investment Partners's AVNS Position: Q1 2019 in Review

Chartwell Investment Partners sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 57,519 shares — an estimated $2.58M sold.

Chartwell Investment Partners first reported a position in AVNS in Q3 2017 and held it in 6 quarters. The position peaked at $6.33M in Q3 2018. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

  • Chartwell Investment Partners reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
  • Chartwell Investment Partners sold 57,519 Avanos Medical shares in Q1 2019, an estimated $2.58M.
  • Chartwell Investment Partners first reported a position in Avanos Medical in Q3 2017 and held it in 6 quarters.
  • Chartwell Investment Partners's Avanos Medical position peaked at $6.33M in Q3 2018.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Chartwell Investment Partners's 13F filing for Q1 2019, filed 11 Apr 2019.